42 articles
Abner Louissaint
Abner Louissaint Jr is an American hematopathologist, Medical Director of Hematology at Massachusetts General Hospital and Harvard associate professor, known for patient-derived xenograft models of rare lymphomas.
Albert Keller
Albert R. Keller is an American pathologist, a 1964 Harvard Medical School graduate, known for histopathological work on Hodgkin's disease and on giant lymph node hyperplasia.
Alfred Ian Lee
Alfred Ian Lee is an American physician-scientist in hematology at Yale School of Medicine, a professor and fellowship program director known for research on thrombosis, platelet disorders, and diagnostic reasoning.
Andreas Engert
Andreas Engert is a German physician-scientist in hematology and oncology at University Hospital Cologne whose German Hodgkin Study Group trials, HD10 and HD18, defined modern PET-adapted therapy for Hodgkin lymphoma.
Barbara Eichhorst
Barbara Eichhorst is a German hematologist and oncologist at the University Hospital of Cologne, deputy head of the German CLL Study Group, known for the CLL13 and RT1 trials.
Bertrand Coiffier
Bertrand Coiffier (1947–2019) was a French hematologist, professor at Lyon, who led the trials establishing R-CHOP as standard treatment for elderly patients with diffuse large B-cell lymphoma.
Christian Gisselbrecht
Christian Gisselbrecht is a French hematologist and clinical trialist, former head of clinical hematology at Hôpital Saint-Louis in Paris, specialized in non-Hodgkin lymphomas and known for the GELA LNH98-5 trial.
Christian Steidl
Christian Steidl is a German-trained Canadian physician-scientist who leads lymphoma research at BC Cancer and is a pathology professor at the University of British Columbia.
Dan L. Longo
Dan L. Longo (born 1949) is an American physician-scientist in immunology and hematology who led lymphoma research at the National Institutes of Health and Harvard.
Daniel Catovsky
Daniel Catovsky (1937–2022) was an Argentine-born British haematologist who defined the diagnosis and treatment of chronic lymphocytic leukemia, working at the Royal Marsden Hospital and Institute of Cancer Research in London.
David Y. Mason
David Y. Mason (1941–2008) was a British immunopathologist and hematologist at Oxford's John Radcliffe Hospital whose 1983 study established monoclonal-antibody staining as a reliable test for lymphoma.
Elaine S. Jaffe
Elaine S. Jaffe is an American hematopathologist who heads the Hematopathology Section at the National Cancer Institute, known for her 1974 paper showing nodular lymphoma arises from follicular B cells.
Elı́as Campo
Elías Campo Güerri, born 1955 in Boltaña, Spain, is a pathologist at the University of Barcelona known for genomic characterization of chronic lymphocytic leukemia and lymphoid neoplasms.
Emili Montserrat
Emili Montserrat is a Spanish hematologist at the University of Barcelona known for research on chronic lymphocytic leukemia and for introducing ZAP-70 as a prognostic marker.
Franck Morschhauser
Franck Morschhauser (born 1967) is a French hematologist at CHU de Lille who became president of the Lymphoma Study Association in 2020 and led the RELEVANCE trial.
Georg Lenz
Georg Lenz is a German hematologist-oncologist directing the Department of Internal Medicine A at University Hospital Münster, known for research on diffuse large B-cell lymphoma.
Gilles Salles
Gilles Salles is a French-born medical oncologist and hematologist specializing in B-cell lymphomas, known for leading the PRIMA trial and chief of the Lymphoma Service at MSK since 2020.
Hanneke C. Kluin‐Nelemans
Hanneke C. Kluin-Nelemans is a Dutch hematologist known for research on mantle cell lymphoma and systemic mastocytosis, and head of hematology at Groningen from 2001 to 2015.
Harald Stein
Harald Stein (born 1942 in Kiel) is a German hematopathologist who discovered Ki-67 and CD30, described new lymphoma entities, and led pathology at the Charité.
Hervé Tilly
Hervé Tilly is a French hematologist-oncologist at the Centre Henri Becquerel in Rouen who led the PRIMA and POLARIX lymphoma trials and directed the center from 2007 to 2017.
Jamés O. Armitage
James O. Armitage is a hematology-oncology physician and Joe Shapiro Professor at the University of Nebraska Medical Center who founded its blood and bone marrow transplant program in 1982.
Jan A. Burger
Jan A. Burger is a German-trained hematologist and professor at MD Anderson Cancer Center who studies chronic lymphocytic leukemia and led the RESONATE-2 trial of ibrutinib.
Jan G. Waldenström
Jan Gösta Waldenström (1906–1996) was a Swedish physician and medical researcher, professor of internal medicine at Lund University, who first described Waldenström macroglobulinemia and classified gammopathies as monoclonal or polyclonal.
Jennifer R. Brown
Jennifer R. Brown is an American physician-scientist who directs the CLL Center at Dana-Farber Cancer Institute and led the ALPINE and AMPLIFY trials that shaped targeted CLL treatment.
Jeremy S. Abramson
Jeremy S. Abramson is a hematologist-oncologist, Professor of Medicine at Harvard Medical School, and Director of the Jon and Jo Ann Hagler Center for Lymphoma at Mass General.
John P. Leonard
John P. Leonard is an American hematologist and medical oncologist who directs the Center for Blood Cancers at NYU Langone Health and led trials of lenalidomide plus rituximab for lymphoma.
Jonathan W. Friedberg
Jonathan W. Friedberg, also known as Jonathan Friedberg, is an American hematologist-oncologist who directs the Wilmot Cancer Institute and studies lymphoma at the University of Rochester.
Judith A. Ferry
Judith A. Ferry is an American diagnostic hematopathologist who directs hematopathology at Massachusetts General Hospital, holds a Harvard pathology chair, wrote the textbook Extranodal Lymphomas, and helped shape the WHO lymphoma classification.
Lucas R. Massoth
Lucas R. Massoth is an American pathologist trained at Massachusetts General Hospital, known for New England Journal of Medicine case reports and genomic studies of rare histiocytic tumors.
Michael Hallek
Michael Hallek (born 1959) is a German hematologist-oncologist at the University Hospital of Cologne who specializes in chronic lymphocytic leukemia and founded the German CLL Study Group.